MM

Mahalakshmi Manjula Chalamcharla

Active Director Managing Director DIN 10154045
DIN 10154045 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahalakshmi Manjula Chalamcharla

Data last updated:

Mahalakshmi Manjula Chalamcharla is a Managing Director at Strada Pharma Marketing Private Limited (since 2023).

DIN 10154045
Primary Designation Managing Director
First Appointment 09 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director09 May 20232023Active

Board colleagues of Mahalakshmi Manjula Chalamcharla

Directorship timeline

Open interactive timeline →
Strada Pharma Marketing Private Limited
Premium access

Shareholding and investment profile for Mahalakshmi Manjula Chalamcharla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahalakshmi Manjula Chalamcharla

Mahalakshmi Manjula Chalamcharla currently holds 1 directorship: Strada Pharma Marketing Private Limited (Managing Director, since 09 May 2023).

Mahalakshmi Manjula Chalamcharla was first appointed on 09 May 2023 as Managing Director at Strada Pharma Marketing Private Limited.

The current boards of Mahalakshmi Manjula Chalamcharla's companies include Basha Hussain Dudekula (Strada Pharma Marketing Private Limited), Sarath Chimakurthi (Strada Pharma Marketing Private Limited), Suresh Kothapalli (Strada Pharma Marketing Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available